Telmisartan And Hydrochlorothiazide
Brands: Micardis Hct · Hydrochlorothiazide + Telmisartan
8 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 18 | SUPPLYING |
| Lifestar Pharma LLC | unknown | 9 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 6 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 4 | SUPPLYING |
| AvKARE | unknown | 3 | SUPPLYING |
| Boehringer Ingelheim Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 0 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 29, 2022RECALLRecall (Class II): Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceut…
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister . — Recalling firm: Glenmark Pharmaceuticals Inc., USA — nationwide
- Jun 29, 2022RECALLRecall (Class II): Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmace…
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister . — Recalling firm: Glenmark Pharmaceuticals Inc., USA — nationwide
Pill